EMS
MCID: ESN002
MIFTS: 48

Eosinophilia-Myalgia Syndrome (EMS) malady

Rare diseases, Blood diseases categories
Download this MalaCard

Summaries for Eosinophilia-Myalgia Syndrome

About this section


Fully expand this MalaCard
Wikipedia:65 Eosinophilia?myalgia syndrome (EMS) is an incurable and sometimes fatal flu-like neurological condition... more...

MalaCards based summary: Eosinophilia-Myalgia Syndrome, also known as syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart, is related to eosinophilia and eosinophilic fasciitis. An important gene associated with Eosinophilia-Myalgia Syndrome is IL5 (interleukin 5 (colony-stimulating factor, eosinophil)), and among its related pathways are Hematopoietic cell lineage and Calcineurin-regulated NFAT-dependent transcription in lymphocytes. The compounds toluene diisocyanate and dpa 1 have been mentioned in the context of this disorder. Affiliated tissues include skin, heart and lung.

Aliases & Classifications for Eosinophilia-Myalgia Syndrome

About this section

Eosinophilia-Myalgia Syndrome, Aliases & Descriptions:

Name: Eosinophilia-Myalgia Syndrome 8 42 10 44 62
Syndrome with Inflammatory and Autoimmune Components That Affect the Skin, Fascia, Muscle, Nerve, Blood Vessels, Lung, and Heart 42
Severe Muscle Pain and Abnormally High Eosinophils 42
 
Eosinophilia Myalgia Syndrome 8
L-Tryptophan Induced Ems 42
Ems 42


Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Rare diseases
Anatomical: Blood diseases


External Ids:

Disease Ontology8 DOID:998
ICD9CM27 710.5
SNOMED-CT57 95416007
MeSH34 D016603

Related Diseases for Eosinophilia-Myalgia Syndrome

About this section

Graphical network of the top 20 diseases related to Eosinophilia-Myalgia Syndrome:



Diseases related to eosinophilia-myalgia syndrome

Symptoms for Eosinophilia-Myalgia Syndrome

About this section

Drugs & Therapeutics for Eosinophilia-Myalgia Syndrome

About this section

Drug clinical trials:

Search ClinicalTrials for Eosinophilia-Myalgia Syndrome

Search NIH Clinical Center for Eosinophilia-Myalgia Syndrome

Genetic Tests for Eosinophilia-Myalgia Syndrome

About this section

Anatomical Context for Eosinophilia-Myalgia Syndrome

About this section

MalaCards organs/tissues related to Eosinophilia-Myalgia Syndrome:

32
Skin, Heart, Lung, Brain, Spinal cord, Skeletal muscle, Liver, T cells

Animal Models for Eosinophilia-Myalgia Syndrome or affiliated genes

About this section

Publications for Eosinophilia-Myalgia Syndrome

About this section

Articles related to Eosinophilia-Myalgia Syndrome:

(show top 50)    (show all 335)
idTitleAuthorsYear
1
AHR activation by tryptophan--pathogenic hallmark of Th17-mediated inflammation in eosinophilic fasciitis, eosinophilia-myalgia-syndrome and toxic oil syndrome? (19941898)
2010
2
Part II. Eosinophilia-Myalgia Syndrome: further correlations between compromised histamine degradation, eosinophilias and myopathies. (17806156)
2007
3
Generation of quinoneimine intermediates in the bioactivation of 3-(N-phenylamino)alanine (PAA) by human liver microsomes: a potential link between eosinophilia-myalgia syndrome and toxic oil syndrome. (17892268)
2007
4
Presence of peak X and related compounds: the reported contaminant in case related 5-hydroxy-L-tryptophan associated with eosinophilia-myalgia syndrome. (10606395)
1999
5
On-line HPLC-tandem mass spectrometry structural characterization of case-associated contaminants of L-tryptophan implicated with the onset of eosinophilia myalgia syndrome. (9817085)
1998
6
Increased activity of the alpha 1(I) procollagen promoter in skin fibroblasts from patients with chronic eosinophilia-myalgia syndrome. (9076948)
1997
7
The eosinophilia-myalgia syndrome and the toxic oil syndrome. Pursuing parallels. (8906286)
1996
8
1995 Bailey K. Ashford lecture. Public health lessons from two catastrophic epidemics: the toxic oil syndrome and the eosinophilia-myalgia syndrome. (8744866)
1996
9
1,1'-Ethylidenebis[L-tryptophan], an impurity in L-tryptophan associated with eosinophilia-myalgia syndrome, stimulates type I collagen gene expression in human fibroblasts in vitro. (8624499)
1995
10
Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia. (8579979)
1995
11
Eosinophilia-myalgia syndrome: a long-term follow-up study. (7660215)
1995
12
P-31 magnetic resonance spectroscopy of skeletal muscle in the eosinophilia-myalgia syndrome: a preliminary study. (8035389)
1994
13
Pharmacogenetic characteristics of the eosinophilia-myalgia syndrome. (7955801)
1994
14
The eosinophilia-myalgia syndrome: lessons from Germany. (8015338)
1994
15
Studies with 1,1'-ethylidenebis(tryptophan), a contaminant associated with L-tryptophan implicated in the eosinophilia-myalgia syndrome. (8184420)
1994
16
Eosinophilia myalgia syndrome: absence of immunoglobulin reactivity suggests a cellular rather than humoral mechanism. (7976226)
1994
17
Eosinophilia-myalgia syndrome in Germany: an epidemiologic review. (8015323)
1994
18
Production of polyclonal antibodies against 1,1'-ethyliden bis[L-tryptophan] (EBT), a potential contaminant causing eosinophilia-myalgia syndrome (EMS). (8475503)
1993
19
Eosinophilia-myalgia syndrome and fasciitis with an active alveolitis. (8355447)
1993
20
Toxic oil syndrome and eosinophilia-myalgia syndrome: May 8-10, 1991, World Health Organization meeting report. (8266108)
1993
21
The eosinophilia-myalgia syndrome: current concepts and future directions. (1551286)
1992
22
Eosinophilia-myalgia syndrome. Natural history in a population-based cohort. (1520057)
1992
23
Eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan. (1386918)
1992
24
Central nervous system involvement in the eosinophilia-myalgia syndrome. (1417516)
1992
25
A histopathologic comparison of Shulman's syndrome (diffuse fasciitis with eosinophilia) and the fasciitis associated with the eosinophilia-myalgia syndrome. (1732344)
1992
26
Identification of decomposition products of 1,1'-ethylidenebis [L-tryptophan], a compound associated with eosinophilia-myalgia syndrome. (1504513)
1992
27
Episodic angioedema with eosinophilia versus eosinophilia-myalgia syndrome. (1583248)
1992
28
Chronic demyelinating polyneuropathy associated with eosinophilia-myalgia syndrome. (1534836)
1992
29
Eosinophilia-myalgia syndrome: the aftermath. (1523446)
1992
30
Endogenous formation of 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3- carboxylic acid in man as the possible causative substance of eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan. (1929872)
1991
31
Environmental pathology. Mast cell and eosinophil infiltration in intestinal mucosa of Lewis rats treated with L-tryptophan implicated in human eosinophilia myalgia syndrome. (2068062)
1991
32
Eosinophilia-myalgia syndrome: the Cleveland Clinic experience. (1934454)
1991
33
Eosinophilia-myalgia syndrome associated with L-tryptophan use. (1984598)
1991
34
L-tryptophan-induced eosinophilia-myalgia syndrome. (1829754)
1991
35
Postmortem studies of the heart in three fatal cases of the eosinophilia-myalgia syndrome. (2058857)
1991
36
Unraveling the eosinophilia-myalgia syndrome. (1863082)
1991
37
Eosinophilia-myalgia syndrome. A clinical case series of 21 patients. New Mexico Eosinophilia-Myalgia Syndrome Study Group. (2001136)
1991
38
Cutaneous manifestations of the L-tryptophan-associated eosinophilia-myalgia syndrome: a spectrum of sclerodermatous skin disease. (2273104)
1990
39
Dermal mucinosis in the eosinophilia-myalgia syndrome. (2241211)
1990
40
The eosinophilia-myalgia syndrome. (2339858)
1990
41
Clinical spectrum of the systemic manifestations of the eosinophilia-myalgia syndrome. (2164712)
1990
42
Eosinophilia-myalgia syndrome: unresolved questions. (2372919)
1990
43
Peripheral neuropathy in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. (2162498)
1990
44
L-tryptophan induced eosinophilia-myalgia syndrome. (2273498)
1990
45
Analysis of L-tryptophan for the etiology of eosinophilia-myalgia syndrome. (2166897)
1990
46
Eosinophilia-myalgia syndrome. Results of national surveillance. (2398610)
1990
47
The eosinophilia-myalgia syndrome with neuritis associated with L-tryptophan use. (2339856)
1990
48
Update: eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan--United States, as of January 9, 1990. (2104651)
1990
49
Eosinophilia-myalgia syndrome with myoclonic jerks. (2292676)
1990
50
Eosinophilia-myalgia syndrome--New Mexico. (2509886)
1989

Variations for Eosinophilia-Myalgia Syndrome

About this section

Expression for genes affiliated with Eosinophilia-Myalgia Syndrome

About this section
Expression patterns in normal tissues for genes affiliated with Eosinophilia-Myalgia Syndrome

Search GEO for disease gene expression data for Eosinophilia-Myalgia Syndrome.

Pathways for genes affiliated with Eosinophilia-Myalgia Syndrome

About this section

Pathways related to Eosinophilia-Myalgia Syndrome according to GeneCards/GeneDecks:

(show all 24)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.6IL5, HLA-DRB1
2
Show member pathways
Calcium signaling in the CD4+ TCR pathway37
9.5IL5, IFNG
39.5IL5, IFNG
49.5IFNG, IL5
59.5IFNG, IL5
69.5IFNG, IL5
7
Show member pathways
9.5HLA-DQA1, HLA-DRB1
89.5HLA-DRB1, HLA-DQA1
9
Show member pathways
Immune response IL 22 signaling pathway60
G protein signaling N RAS regulation pathway60
9.5HLA-DRB1, HLA-DQA1
10
Show member pathways
9.5HLA-DRB1, HLA-DQA1
119.5HLA-DRB1, HLA-DQA1
129.4IFNG, IDO1
13
Show member pathways
Immune response IL 12 induced IFN gamma production60
9.3IFNG, HLA-DRB1
149.3IFNG, HLA-DRB1
159.0IL5, IFNG, HLA-DRB1
16
Show member pathways
8.9HLA-DQA1, HLA-DRB1, IFNG
178.9HLA-DQA1, HLA-DRB1, IFNG
18
Show member pathways
8.9IFNG, HLA-DRB1, HLA-DQA1
198.9IFNG, HLA-DRB1, HLA-DQA1
20
Show member pathways
8.9IFNG, HLA-DRB1, HLA-DQA1
218.9IFNG, HLA-DRB1, HLA-DQA1
22
Show member pathways
8.5IL5, IFNG, HLA-DRB1, HLA-DQA1
23
Show member pathways
8.5IL5, IFNG, HLA-DRB1, HLA-DQA1
24
Show member pathways
8.5HLA-DQA1, HLA-DRB1, IFNG, IL5

Compounds for genes affiliated with Eosinophilia-Myalgia Syndrome

About this section

Compounds related to Eosinophilia-Myalgia Syndrome according to GeneCards/GeneDecks:

(show all 40)
idCompoundScoreTop Affiliating Genes
1toluene diisocyanate4410.2HNMT, IL5
2dpa 1449.9HLA-DQA1, HLA-DRB1
3pirfenidone44 6110.9IL5, IFNG
4amphotericin b449.9IL5, IFNG
5lapatinib44 50 1111.9HLA-DQA1, HLA-DRB1
6il-12449.9IFNG, IL5
7imiquimod44 61 28 1112.9IL5, IFNG
81-methyltryptophan449.9IDO1, IFNG
9con a449.9IL5, IFNG
103-hydroxyanthranilic acid44 2410.8IDO1, IFNG
11gm-csf44 2810.8IL5, IFNG
12kynurenine449.8IFNG, IDO1
13budesonide44 50 1111.8IFNG, IL5
14fluticasone propionate44 50 61 1112.8IL5, IFNG
15indoleamine449.8IFNG, IDO1
16polyinosinic-polycytidylic acid449.8IFNG, IL5
17rolipram44 61 2811.8IL5, IFNG
18methylcellulose449.8IFNG, IL5
19il 10449.8IL5, IFNG
20s-nitroso-n-acetylpenicillamine449.8IFNG, IDO1
212,5-oligoadenylate449.7IDO1, IFNG
22anti-fungal449.7IFNG, IL5
23gold sodium thiomalate449.7HLA-DRB1, IFNG
24tarc449.7IFNG, IL5
25l-nmma449.7IFNG, IDO1
26glucosamine44 24 1111.6IFNG, IL5
27infliximab44 50 1111.6IDO1, IFNG
28ivig449.6IFNG, IL5
29l-tryptophan50 28 44 24 1113.5IDO1, IFNG, IL5
30poly(i-c)449.5IL5, IFNG, IDO1
31thalidomide44 50 61 1112.5IL5, IFNG
32histamine44 28 2411.5IFNG, IL5, HNMT
33rantes449.5IL5, IFNG, IDO1
34glatiramer acetate44 1110.4IL5, IFNG, HLA-DRB1
35allergens449.4IL5, IFNG, HLA-DRB1
36neopterin449.3IDO1, IFNG
37pge2449.3IL5, IFNG, IDO1
38thymidine44 2410.1IL5, IFNG, IDO1
39cycloheximide448.8IL5, IFNG, IDO1
40arginine448.5HLA-DQA1, HLA-DRB1, IDO1, IFNG, IL5

GO Terms for genes affiliated with Eosinophilia-Myalgia Syndrome

About this section

Cellular components related to Eosinophilia-Myalgia Syndrome according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1MHC class II protein complexGO:0426139.6HLA-DRB1, HLA-DQA1
2integral component of lumenal side of endoplasmic reticulum membraneGO:0715569.6HLA-DRB1, HLA-DQA1
3clathrin-coated endocytic vesicle membraneGO:0306699.6HLA-DRB1, HLA-DQA1
4transport vesicle membraneGO:0306589.5HLA-DQA1, HLA-DRB1
5endocytic vesicle membraneGO:0306669.5HLA-DRB1, HLA-DQA1
6ER to Golgi transport vesicle membraneGO:0125079.4HLA-DRB1, HLA-DQA1
7trans-Golgi network membraneGO:0325889.2HLA-DRB1, HLA-DQA1

Biological processes related to Eosinophilia-Myalgia Syndrome according to GeneCards/GeneDecks:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of interleukin-12 productionGO:0327359.5IFNG, IDO1
2antigen processing and presentation of exogenous peptide antigen via MHC class IIGO:0198869.5HLA-DRB1, HLA-DQA1
3T cell costimulationGO:0312959.4HLA-DRB1, HLA-DQA1
4T cell receptor signaling pathwayGO:0508529.2HLA-DRB1, HLA-DQA1
5immune responseGO:0069559.2HLA-DQA1, HLA-DRB1, IL5
6interferon-gamma-mediated signaling pathwayGO:0603339.0HLA-DQA1, HLA-DRB1, IFNG
7cytokine-mediated signaling pathwayGO:0192218.7IL5, IFNG, HLA-DRB1, HLA-DQA1

Molecular functions related to Eosinophilia-Myalgia Syndrome according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1MHC class II receptor activityGO:0323959.5HLA-DRB1, HLA-DQA1

Products for genes affiliated with Eosinophilia-Myalgia Syndrome

About this section
  • Antibodies
  • Proteins
  • Lysates

Sources for Eosinophilia-Myalgia Syndrome

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
34MeSH
35MESH via Orphanet
36MGI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
51PubMed
52QIAGEN
58SNOMED-CT via Orphanet
62UMLS
63UMLS via Orphanet